Nexosome Oncology is a Durham, NC-based health care startup that was founded in 2021. The company's slogan, "Novel Diagnostic Proteomics Platform for Cancer," encapsulates its core mission. As of 22 November 2021, Nexosome Oncology successfully secured a $3.65M Seed Round investment, with Keyhorse Capital, OCA Ventures, and VisionTech Partners participating as investors. This latest investment will likely play a pivotal role in bolstering the development and deployment of Nexosome Oncology's innovative diagnostic solutions for cancer.
No recent news or press coverage available for Nexosome Oncology.